熱門資訊> 正文
DeliverSpring Health报告第三季度初步收入，提高25财年指导
2025-10-21 04:23
- BrightSpring Health Services, Inc. (NASDAQ:BTSG) on Monday reported preliminary third-quarter 2025 revenue of $3.33 billion, up 28% from $2.60 billion a year earlier.
- Adjusted EBITDA rose 37% to $160 million, while net income was $37.5 million versus a $25.7 million loss in the third quarter 2024.
- The company raised full-year 2025 guidance, projecting revenue of $12.4–12.7 billion, up 23–26%, and adjusted EBITDA of $605–615 million, up 32–34%.
- Revenue growth is driven by the Pharmacy segment ($10.95–11.2 billion) and Provider segment ($1.45–1.5 billion).
- BrightSpring plans to report final third-quarter results on Oct. 28 and host a conference call the same day.
- BTSG -2.19% after hours to $29.8.
- Source: Press Release
More on BrightSpring Health Services
- BrightSpring Health Services, Inc. (BTSG) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
- BrightSpring Health Services, Inc. (BTSG) Q2 2025 Earnings Call Transcript
- BrightSpring Health Services, Inc. 2025 Q2 - Results - Earnings Call Presentation
- BrightSpring to join S&P SmallCap 600, replacing Veritex
- BrightSpring raises 2025 adjusted EBITDA guidance to $605M while expanding specialty pharmacy and infusion growth
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
